CIA
DMK

Cape Investment Advisory’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Cape Investment Advisory’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$1 – 1206
2023
Q4 		$1 Hold
1
– – ﹤0.01% 1132
2023
Q3 		$1 Hold
1
– – ﹤0.01% 928
2023
Q2 		$2 Hold
1
– – ﹤0.01% 908
2023
Q1 		$12 Buy
+1
New +$13 ﹤0.01% 958

Other funds holding DMK

CPA
Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return
OPTFSNA
Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

Cape Investment Advisory's DMK Position: Q1 2024 in Review

Cape Investment Advisory sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 1 share — an estimated $1 sold.

Cape Investment Advisory first reported a position in DMK in Q1 2023 and held it in 4 quarters. The position peaked at $12 in Q1 2023. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

  • Cape Investment Advisory reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
  • Cape Investment Advisory sold 1 DMK Pharmaceuticals Corporation Common Stock share in Q1 2024, an estimated $1.
  • Cape Investment Advisory first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2023 and held it in 4 quarters.
  • Cape Investment Advisory's DMK Pharmaceuticals Corporation Common Stock position peaked at $12 in Q1 2023.
  • 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Cape Investment Advisory's 13F filing for Q1 2024, filed 21 Jun 2024.